Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties

JAMA

Volumn 275, Issue 19, 1996, Pages 1483-1488

  Fiscus, Susan A ^a,b   Adimora, Adaora A ^a   Schoenbach, Victor J ^b   Lim, Wilma ^a   McKinney, Ross ^c   Rupar, David ^d   Kenny, Jean ^e   Woods, Charles ^f   Wilfert, Catherine ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d CAROLINAS MEDICAL CENTER   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; PERINATAL INFECTION; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SERODIAGNOSIS; SEROEPIDEMIOLOGY; URBAN AREA; VIRUS TRANSMISSION;

EID: 0029985671     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.19.1483     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention. Update: AIDS among women - United States, 1994. MMWR Morb Mortal Wkly Rep. 1995;44:81-84.
2. Centers for Disease Control and Prevention. Update: acquired immunodeficiency syndrome - United States, 1991. MMWR Morb Mortal Wkly Rep. 1992;41:463-468.
3. Davis SF, Byers RH, Lindgren ML, Caldwell MB, Karon JM, Gwinn M. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA. 1995;247:952-955.
4. Gwinn M, Pappaioanou M, George JR, et al. Prevalence of HIV infection in childbearing women in the United States: surveillance using newborn blood samples. JAMA 1991;265:1704-1708.
5. Connor EM, Sperling RS, Gelbert R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994; 331:1173-1180.
6. Centers for Disease Control and Prevention. Zidovudine for the prevention of HIV transmission from mother to infant. MMWR Morb Mortal Wkly Rep. 1994;43:285-287.
7. Centers for Disease Control and Prevention. US Public Health Service recommendations for HIV counseling and voluntary testing for pregnant women. MMWR Morb Mortal Wkly Rep. 1995;44(RR-7):1-15.
8. Simonds RJ, Lindegren ML, Thomas P, et al. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. N Engl J Med. 1996;332:786-790.
9. Centers for Disease Control and Prevention. Revised guidelines for prophylaxis against Pneumocystis carinni pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1995;44 (RR-4):1-11.
10. Report of a consensus workshop, Siena, Italy, January 17-18, 1992: early diagnosis of HIV infection in infants. J Acquir Immune Defic Syndr. 1992; 5:1169-1178.
11. Sison AV, Campos JM. Laboratory methods for early detection of human immunodeficiency virus type 1 in newborns and infants. Clin Microbiol Rev. 1992;5:238-247.
12. McIntosh K, Pitt J, Brambilla D, et al. Blood culture in the first six months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. J Infect Dig. 1994;170:996-1000.
13. Wasser SC, Gwinn M, Fleming P. Urban-nonurban distribution of HIV infection in childbearing women in the United States. J Acquir Immune Defic Syndr. 1993;6:1035-1042.
14. Hollinger FB, ed. ACTG Virology Manual for HIV Laboratories. 4th ed. Bethesda, Md: National Institute of Allergy and Infectious Diseases; 1994.
15. Fiscus SA, Welles SL, Spector SA, Lathey JL. Length of time for human immunodeficiency virus cultures. J Clin Microbiol. 1995;33:246-247.
16. Hammer S, Crumpacker C, D'Aquila R, et al. Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee. J Clin Microbiol. 1994;31:2557-2564.
17. Rumley RL, Shappley NC, Waivers LE, Esinhart JD. AIDS in rural eastern North Carolina - patient migration: a rural AIDS burden. AIDS. 1991;5:1373-1378.
18. Grant C, McKinney RE, Weedy C, Katz CL, Wilfert CM. The introduction of human immunodeficiency virus into the North Carolina pediatric population. Pediatrics. 1992;90:174-177.
19. Helms CM. Rural HIV infection: the window of opportunity for action is still wide open. J Gen Intern Med. 1993;8:210-212.
20. Hsu H-W, Moye J, Kunches L, et al. Perinatally acquired human immunodeficiency virus infection: extent of clinical recognition in a population-based cohort. Pediatr Infect Dis. 1992;11:941-945.
21. Maldonado YA, Wang NE, Caldwell B, Northern California Pediatric HIV Consortium. Factors associated with early clinical recognition of children with perinatal human immunodeficiency virus infection. J Infect Dis. 1995;171:689-692.
22. Coplan J, Dye TD, Contello KA, Cunningham CK, Kirkwood K, Weiner LB. Failure to identify human immunodeficiency virus-seropositive newborns: epidemiology and enrollment patterns in a predominantly white, nonurban setting. Pediatrics. 1995;96:1083-1089.
23. St Louis ME, Kamenga M, Brown C, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993;269:2851-2859.